EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lactylation in kidney diseases: a review of regulatory mechanisms and therapeutic prospects

Yuxi Feng, Jinjin Wang, Jiawei Cao, Xuan Zhang, Mengyu Liang, Yi Cai, Jiaqi Wang, Chenxi Lu, Runzhi Zhu, Qinyang Jin, Zhuanxin Chen, Qin Zhu

Frontiers in Cell and Developmental Biology · 27.07.2026 · 14

DOI: 10.3389/fcell.2026.1836185 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 27.07.2026. Verfasst von Yuxi Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hangzhou TCM Hospital Affiliated with Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactylation, a novel post-translational modification (PTM) of proteins, plays a critical role in various diseases through the regulation of gene expression and metabolic reprogramming. Recent studies have increasingly highlighted its pathological and physiological relevance in kidney diseases. Lactylation exerts pleiotropic effects across diverse renal pathologies, from promoting fibrotic progression in Chronic kidney disease (CKD) to modulating immune evasion in clear cell renal cell carcinoma (ccRCC), thereby positioning it at the epicenter of metabolic-epigenetic interplay in kidney disease. This review systematically delineates the dynamic regulatory mechanisms of PTMs and their pivotal roles and current research status in kidney diseases, explores the latest advancements in lactylation research concerning CKD, acute kidney injury (AKI), and ccRCC, and discusses its potential as a therapeutic target. By synthesizing current findings, the article aims to offer new perspectives and directions for future treatments of kidney diseases and the development of targeted therapies.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurychronic kidney diseaselactylationpost-translational modificationrenal cell carcinoma

Autor:innen und Institutionen

  • Department of Nephrology, Hangzhou TCM Hospital Affiliated with Zhejiang Chinese Medical University, Hangzhou, China.
  • National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • HeartCenter, Department of Geriatrics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China.
  • Department of Endocrinology, Chun'an County Traditional Chinese Medicine Hospital, Hangzhou, China.

Zitieren

APA

Feng, Y., Wang, J., Cao, J., Zhang, X., Liang, M., Cai, Y., Wang, J., Lu, C., Zhu, R., Jin, Q., Chen, Z., & Zhu, Q. (2026). Lactylation in kidney diseases: a review of regulatory mechanisms and therapeutic prospects. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1836185

Vancouver

Feng Y, Wang J, Cao J, Zhang X, Liang M, Cai Y, et al. Lactylation in kidney diseases: a review of regulatory mechanisms and therapeutic prospects. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1836185

BibTeX
@article{Feng2026,
  author = {Feng, Yuxi and Wang, Jinjin and Cao, Jiawei and Zhang, Xuan and Liang, Mengyu and Cai, Yi and Wang, Jiaqi and Lu, Chenxi and Zhu, Runzhi and Jin, Qinyang and Chen, Zhuanxin and Zhu, Qin},
  title = {Lactylation in kidney diseases: a review of regulatory mechanisms and therapeutic prospects},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1836185}
}
Kostenlos starten →